Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips With the healthcare sector poised to grow significantly in the coming years, healthcare stocks to buy present a fantastic opportunity for investors. Healthcare is something that everyone will need at some point in their lives, ...
Eli Lilly 's (NYSE: LLY) biosimilar drug known as Rezvoglar was given the green light by the U.S. Food and Drug Administration (FDA) to be marketed as an interchangeable to Sanofi 's (NASDAQ: SNY) Lantus long-acting insulin. This follows the FDA's approval of Rezvoglar as a biosimil...
Viatris Announces Appointments of Scott A. Smith and Elisha W. Finney to the Company's Board of Directors PR Newswire Directors Neil Dimick and Ian Read Retire PITTSBURGH , Dec. 29, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global he...
Bargain hunting for inexpensive dividend stocks is a good habit if you're trying to build a passive income stream from your investments. If you have the wherewithal to buy shares of companies that have taken a beating during the latest bear market, procuring stocks while their prices are lower th...
Dividend hikes aren't automatic, but they can sometimes be predictable. As long as a company is doing well and an increase to the dividend looks probable, the timing of the announcement often will come at around the same time as it did in the previous year. Three stocks that I expect will ann...
Viatris Inc. to Participate in 41st Annual J.P. Morgan Healthcare Conference PR Newswire PITTSBURGH , Dec. 23, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the 41 st Annual ...
Viatris Announces Donations Totaling $1 Million to Provide Aid Supporting Access to Healthcare, Food Security and Water Stewardship PR Newswire The contribution includes donations to four organizations: Direct Relief, World Central Kitchen, WaterAid and World Food Program US...
Viatris Announces Approval of Emissions Reduction Targets by the Science Based Target initiative (SBTi) PR Newswire PITTSBURGH , Dec. 14, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that its near-term sci...
Summary Humira's international sales were $603 million in Q3 2022, down 25.7% year-over-year, and this is mainly due to increased competition from biosimilars in Europe. AbbVie's EBITDA was $7,235 million in Q3 2022, up 2.8% year-on-year. The largest contribution to the company's re...
Summary We've witnessed such a quick and sharp correction in the stock market that the S&P 500 nearly moved from bear-market to bull-market in a matter of weeks. Nonetheless, there are still plenty of signs suggesting that this rapid move isn't going to last much longer, therefore w...
News, Short Squeeze, Breakout and More Instantly...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / No country can make every medicine people need, and no medicine is made in every country. If a country or region relies on supply only from within their region and they experience a crisis, there is a risk people won't get the medicines they need, w...
NORTHAMPTON, MA / ACCESSWIRE / July 18, 2024 / Viatris is a global healthcare company focused on bringing high-quality medicines to patients through a hybrid approach that bridges the traditional divide between generics and brands, combining the best of both, to more holistically address healthc...
2024-07-15 10:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...